Abstract
Obesity is a major problem in developed countries and the development of an effective treatment is an important area of research. In order to reach this goal, we must first know how metabolism and appetite are controlled, both in the periphery, as well as in the central nervous system. Due to the increased interest in this area of research, our understanding of the neuroendocrine control of food intake and energy expenditure has increased dramatically in recent years. New neuropeptides have been identified and new metabolic roles of previously known neuropeptides and neurotransmissors have been demonstrated. This chapter will briefly describe the various brain areas involved in metabolic control, concentrating on the hypothalamus and the specific nuclei of this brain area most intimately involved in the control of appetite and metabolism. Special attention will be paid to the hypothalamic neuronal populations that produce neuropeptide Y (NPY)/agouti-related protein (AgRP) and proopiomelanortin (POMC)/cocaine- and amphetamine-regulated transcript (CART). These two neuronal populations are central to metabolic and have been the subject of much investigation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahima, R.S. (2005). Central actions of adipocyte hormones. Trends in Endocrinology and Metabolism, 16, 307–313.
Ahima, R.S. & Lazar, M.A. (2008). Adipokines and the peripheral and neural control of energy balance. Molecular Endocrinology, 22, 1023–1031.
Ahima, R.S., Qi, Y., Singhal, N.S., Jackson, M.B., & Scherer, P.E. (2006). Brain adipocytokine action and metabolic regulation. Diabetes, 55, S145–S154.
Air, E.L., Strowski, M.Z., Benoit, S.C., Conarello, S.L., Salituro, G.M., Guan, X.M., Liu, K., Woods, S.C., & Zhang, B.B. (2002). Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity. Nature Medicine, 8, 179–183.
Anand, B.K., & Brobeck, J.R. (1951). Localization of feeding center in the hypothalamus of the rat. Proceedings of the Society for Experimental Biology and Medicine, 11, 323–324.
Andersson, U., Filipsson, K., Abbott, C.R., Woods, A., Smith, K., Bloom, S.R., Carling D., & Small, C.J. (2004). AMP-activated protein kinase plays a role in the control of food intake. The Journal of Biological Chemistry, 279, 12005–12008.
Antunes, T.T., Gagnon, A., Bell, A., & Sorisky, A. (2005). Thyroid-stimulating hormone stimulates interleukin-6 release from 3T3-L1 adipocytes through a cAMP-protein kinase A pathway. Obesity Research, 13, 2066–2071.
Arch, J.R. (2005). Central regulation of energy balance: inputs, outputs and leptin resistance. Proceedings of the Nutrition Society, 64, 39–46.
Argente, J., Barrios, V., Chowen, J.A., Sinha, M.K., & Considine, R.V. (1997). Leptin plasma levels in healthy Spanish children and adolescents, children with obesity, and adolescents with anorexia nervosa and bulimia nervosa. The Journal of Pediatrics, 131, 833–838.
Asakawa, A., Inui, A., Ueno, N., Fujimiya, M., Fujino, M.A., & Kasuga, M. (1999). Mouse pancreatic polypeptide modulates food intake, while not influencing anxiety in mice. Peptides, 20, 1445–1448.
Baggio, L.L., Huang, Q., Brown, T.J., & Drucker, D.J. (2004). Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure. Gastroenterology, 127, 546–558.
Baldanzi, G., Filigheddu, N., Cutrupi, S., Catapano, F., Bonissoni, S., Fubini, A., Malan, D., Baj, G., Granata, R., Broglio, F., Papotti, M., Surico, N., Bussolino, F., Isgaard, J., Deghenghi, R., Sinigaglia, F., Prat, M., Muccioli, G., Ghigo, E., & Graziani, A. (2002). Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. The Journal of Cell Biology, 159, 1029–1037.
Banks, W.A. (2006). The blood-brain barrier as a regulatory interface in the gut-brain axes. Physiology & Behavior, 89, 472–476.
Bell, A., Gagnon, A., Dods, P., Papineau, D., Tiberi, M., & Sorisky, A. (2002). TSH signaling and cell survival in 3T3-L1 preadipocytes. American Journal of Physiology. Cell Physiology, 283, C1056–C1064.
Berthoud, H.R., Sutton, G.M., Townsend, R.L., Patterson, L.M., & Zheng, H. (2006). Brainstem mechanisms integrating gut-derived satiety signals and descending forebrain information in the control of meal size. Physiology & Behavior, 89, 517–524.
Boston, B.A., & Cone, R.D. (1996). Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line. Endocrinology, 137, 2043–2050.
Broberger, C. (1999). Hypothalamic cocaine-and amphetamine-regulated transcript (CART) neurons: histochemical relationship to thyrotropin-releasing hormone, melanin-concentrating hormone, orexin/hypocretin and neuropeptide Y. Brain Research, 289, 101–113.
Bruning, J.C., Gautam, D., Burks, D.J., Gillette, J., Schubert, M., Orban, P.C., Klein, R., Krone, W., Muller-Wieland, D., & Kahn, C.R. (2000). Role of brain insulin receptor in control of body weight and reproduction. Science, 289, 2122–2125.
Ceccatelli, S., Eriksson, M., & Hokfelt, T. (1989). Distribution and coexistence of corticotropin-releasing factor-, neurotensin-, enkephalin-, cholecystokinin-, galanin- and vasoactive intestinal polypeptide/peptide histidine isoleucine-like peptides in the parvocellular part of the paraventricular nucleus. Neuroendocrinology, 49, 309–323.
Chartrel, N., Alvear-Perez, R., Leprince, J., Iturrioz, X., Reaux-Le Goazigo, A., Audinot, V., Chomarat, P., Coge, N., Nosjean, O., Rodriguez, M., Galizzi, J.P., Boutin, J.A., Vaudry, H., & Llorens-Cortes, C. (2007). Comment on “Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin’s effects on food intake”. Science, 315, 766.
Chen, P., Williams, S.M., Grove, K.L., & Smith, M.S. (2004). Melanocortin 4 receptor-mediated hyperphagia and activation of neuropeptide Y expression in the dorsomedial hypothalamus during lactation. The Journal of Neuroscience, 24, 5091–5100.
Cho, K.J., Shim, J.H., Cho, M.C., Choe, Y.K., Hong, J.T., Moon, D.C., Kim, J.W., & Yoon, D.Y. (2005). Signaling pathways implicated in alpha-melanocyte stimulating hormone-induced lipolysis in 3T3-L1 adipocytes. The Journal of Cell Biochemistry, 96, 869–878.
Chowen, J., Fraser, H.M., Vician, L., Damassa, D.A., Clifton, D.K., & Steiner, R.A. (1989). Testosterone regulation of proopiomelanocortin messenger ribonucleicacid in the arcuate nucleus of the male rat. Endocrinology, 124, 1697–1702.
Clement, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.M., Basdevant, A., Bougneres, P., Lebouc, Y., Froguel, P., & Guy-Grand, B. (1998). A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature, 392, 398–401.
Cone, R.D. (2000). The corticotropin-releasing hormone system and feeding behavior – a complex web begins to unravel. Endocrinology, 141, 2713–2714.
Cooney, R.N. (2002). Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway. Shock, 17, 83–90.
Cota, D., Marsicano, G., Tschoep, M., Gruebler, Y., Flachskamm, C., Schubert, M., Auer, D., Yassouridis, A., Thöne-Reineke, C., Ortmann, S., Tomassoni, F., Cervino, C., Nisoli, E., Linthorst, A.C., Pasquali, R., Lutz, B., Stalla, G.K., & Pagotto, U. (2003). The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. The Journal of Clinical Investigation, 112, 423–431.
Cunningham, M.J., Scarlett, J.M., & Steiner, R.A. (2002). Cloning and distribution of galaninlike peptide mRNA in the hypothalamus and pituitary of the macaque. Endocrinology, 143, 755–776.
de Lecea, L., Kilduff, T.S., Peyron, C., Gao, X., Foye, P.E., Danielson, P.E., Fukuhara, C., Battenberg, E.L., Gautvik, VT., Bartlett, F.S. II, Frankel, W.N., van der Pol, A.N., Bloom, F.E., Gautvik, K.M., & Sutcliffe, J.G. (1998). The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proceedings of the National Academy of Science of the United States of America, 95, 322–327.
del Rincon, J.P., Iida, K., Gaylinn, B.D., McCurdy, C.E., Leitner, J.W., Barbour, L.A., Kopchick, J.J., Friedman, J.E., Draznin, B., & Thorner, M.O. (2007). Growth hormone regulation of p85alpha expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance. Diabetes, 56, 1638–1646.
Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 1946–1949.
Di Marzo, V., Goparaju, S.K., Wang, L., Liu, J., Batkai, S., Jarai, Z., Fezza, F., Miura, G.I., Palmiter, R.D., Sugiura, T., & Kunos, G. (2001). Leptin regulated endocannabinoids are involved in maintaining food intake. Nature, 410, 822–825.
Dunbar, J., Lapanowski, K., Barnes, M., & Rafols, J. (2005). Hypothalamic agouti-related protein immunoreactivity in food-restricted, obese, and insulin-treated animals: evidence for glia cell localization. Experimental Neurology, 191, 184–192.
Ellacott, K.L., & Cone, R.D. (2004). The central melanocortin system and the integration of short- and long-term regulators of energy homeostasis. Recent Progress in Hormone Research, 59, 395–408.
Flint, D.J., Binart, N., Kopchick, J., & Kelly, P. (2003). Effects of growth hormone and prolactin on adipose tissue development and function. Pituitary, 6, 97–102.
Fort, P., Salvert, D., Hanriot, L., Jego, S., Shimizu, H., Hashimoto, K., Mori, M., & Luppi, P.H. (2008). The satiety molecule nesfatin-1 is co-expressed with melanin concentrating hormone in tuberal hypothalamic neurons of the rat. Neuroscience, 155, 174–181.
Friedberg, M., Zoumakis, E., Hiroi, N., Bader, T., Chrousos, G.P., & Hochberg, Z. (2003). Modulation of 11 beta-hydroxysteroid dehydrogenase type 1 in mature human subcutaneous adipocytes by hypothalamic messengers. The Journal of Clinical Endocrinology and Metabolism, 88, 385–393.
Ganjavi, H., & Shapiro, C.M. (2007). Hypocritin/Orexin: a molecular link between sleep, energy regulation and pleasure. Journal of Neuropsychiatry and Clinical Neuroscience, 19, 413–419.
Gerozissis, K. (2008). Brain insulin, energy and glucose homeostasis: genes, environment and metabolic pathologies. European Journal of Pharmacology, 585, 38–49.
Grill, H.J., & Kaplan, J.M. (2002). The neuroanatomical axis for control of energy balance. Frontiers in Neuroendocrinology, 23, 2–40.
Gross, P.M. (1992). Circumventricular organ capillaries. Progress in Brain Research, 91, 219–233.
Gutzwiller, J.P., Göke, B., Drewe, J., Hildebrand, P., Ketterer, S., Handschin, D., Winterhalder, R., Conen, D., & Beglinger, C. (1999). Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut, 44, 81–86.
Hahn, T.M., Breininger, J.F., Baskin, D.G., & Schwartz, M.W. (1998). Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nature Neuroscience, 1, 271–272.
Hakansson, M.L., Brown, H., Ghilardi, N., Skoda, R.C., & Meister, B. (1998). Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. The Journal of Neuroscience, 18, 559–572.
Hakansson, M., de Lecea, L., Sutcliffe, J.G., Yanagisawa, M., & Meister, B. (1999). Leptin receptor- and STAT3-immunoreactivities in hypocretin/orexin neurones of the lateral hypothalamus. Journal of Neuroendocrinology, 11, 653–663.
Heatherington, A.W., & Ranson, S.W. (1940). Hypothalamic lesions and adiposity in the rat. Anatomical Records, 78, 149–172.
Hensen, K.R., Krasnow, S.M., Nolan, M.A., Fraley, G.S., Baumgartner, J.W., Clifton, D.K., & Steiner, R.A. (2003). Activation of the sympathetic nervous system by galanin-like peptide--a possible link between leptin and metabolism. Endocrinology, 144, 4709–4717.
Higuchi, H., Hasegawa, A., & Yamaguchi, T. (2005). Transcriptional regulation of neuronal genes and its effect on neural functions: transcriptional regulation of neuropeptide Y gene by leptin and its effect on feeding. Journal of Pharmacological Sciences, 98, 225–231.
Howlett, A.C. (2002). The cannabinoid receptors. Prostaglandins Other Lipid Mediators, 68–69, 619–631.
Hoyda, T.D., Samson, W.K., & Ferguson, A.V. (2009). Adiponectin depolarizes parvocellular paraventricular nucleus neurons controlling neuroendocrine and autonomic function. Endocrinology, 150, 832–840.
Huang, Q., Rivest, R., & Richard, D. (1998). Effects of leptin on corticotropin-releasing factor (CRF) synthesis and CRF neuron activation in the paraventricular hypothalamic nucleus of obese (ob/ob) mice. Endocrinology, 139, 1524–1532.
Huo, L., Grill, H.J., & Bjorbaek, C. (2006). Divergent regulation of proopiomelanocortin neurons by leptin in the nucleus of the solitary tract and in the arcuate hypothalamic nucleus. Diabetes, 55, 567–573.
Iwen, K.A., Senyaman, O., Schwartz, A., Drenckhan, M., Meier, B., Hadaschik, D., & Klein J. (2008). Melanocortin crosstalk with adipose functions: ACTH directly induces insulin resistance, promotes a pro-inflammatory adipokine profile and stimulates UCP-1 in adipocytes. Journal of Endocrinology, 196, 465–472.
Jayasena, C.N., & Bloom, S.R. (2008). Role of gut hormones in obesity. Endocrinology Metabolism Clinics of North America, 37, 769–787.
Juréus, A., Cunningham, M.J., Li, D., Johnson, J.L., Krasnow, S.M., Teklemichael, D.N., Clifton, D.K., & Steiner, R.A. (2001). Distribution and regulation of galanin-like peptide (GALP) in the hypothalamus of the mouse. Endocrinology, 142, 5140–5144.
Kastin, A.J., & Pan, W. (2000). Dynamic regulation of leptin entry into brain by the blood-brain barrier. Regulatory Peptides, 92, 37–43.
Katsuura, G., Asakawa, A., & Inui, A. (2002). Roles of pancreatic polypeptide in regulation of food intake. Peptides, 23, 323–329.
Kim, M.S., Rossi, M., Abusnana, S., Sunter, D., Morgan, D.G., Small, C.J., Edwards, C.M., Heath, M.M., Stanley, S.A., Seal, L.J., Bhatti, J.R., Smith, D.M., Ghatei, M.A., & Bloom, S.R. (2000). Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes, 49, 177–182.
Kim, E.M., Grace, M.K., O’Hare, E., Billington, C.J. & Levine A.S. (2002). Injection of alpha-MSH, but not beta-endorphin, into the PVN decreases POMC gene expression in the ARC. NeuroReport, 13, 497–500.
Kishi, T., Aschkenasi, C.J., Lee, C.E., Mountjoy, K.G., Saper, C.B. & Elmquist, J.K. (2003). Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat. Journal of Comparative Neurology, 457, 213–235.
Kohno, D., Nakata, M., Maejima, Y., Shimizu, H., Sedbazar, U., Yoshida, N., Dezaki, K., Onaka, T., Mori, M., & Yada, T. (2008). Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinology, 149, 1295–1301.
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999). Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 402, 656–660.
Korner, A., Kratzsch, J., & Kiess, W. (2005). Adipocytokines: leptin–the classical, resistin–the controversical, adiponectin–the promising, and more to come. Best Practice & Research Clinical Endocrinology & Metabolism, 19, 525–546.
Krahn, D.D., Gosnell, B.A., Levine, A.S., & Morley, J.E. (1988). Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects. Brain Research, 443, 63–69.
Krasnow, S.M., Fraley, G.S., Schuh, S.M., Baumgartner, J.W., Clifton, D.K., & Steiner, R.S. (2003). A role for galanin-like peptide in the integration of feeding, body weight regulation, and reproduction in the mouse. Endocrinology, 144, 813–822.
Lam, T.K., Schwartz, G.J., & Rossetti, L. (2005). Hypothalamic sensing of fatty acids. Nature Neuroscience, 8, 579–584.
Leibowitz, S.F. (1998). Differential functions of hypothalamic galanin cell grows in the regulation of eating and body weight. Annals of the New York Academy of Science, 863, 206–220.
López, M., Lelliott, C.J., Tovar, S., Kimber, W., Gallego, R., Virtue, S., Blount, M., Vázquez, M.J., Finer, N., Powles, T.J., O’Rahilly, S., Saha, A.K., Diéguez, C., & Vidal-Puig A.J. (2006). Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA. Diabetes, 55, 1327–1336.
Ludwig, D.S., Tritos, N.A., Mastaitis, J.W., Kulkarni, R., Kokkotou, E., Elmquist, J., Lowell, B., Flier, J.S. & Maratos-Flier, E. (2001). Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. The Journal of Clinical Investigation, 107, 379–386.
Lutz, T.A. (2006). Amylinergic control of food intake. Physiology & Behavior, 89, 465–471.
Martínez, A., Kapas, S., Miller, M.J., Ward, Y., & Cuttitta, F. (2000). Coexpression of receptors for adrenomedullin, calcitonin gene-related peptide, and amylin in pancreatic beta-cells. Endocrinology, 141, 406–411.
Marty, N., Dallaporta, M., Foretz, M., Emery, M., Tarussio, D., Bady, I., Binnert, C., Beermann, F., & Thorens, B. (2005). Regulation of glucagon secretion by glucose transporter type 2 (glut2) and astrocyte-dependent glucose sensors. The Journal of Clinical Investigation, 115, 3545–3553.
Marty, N., Dallaporta, M., & Thorens, B. (2007). Brain glucose sensing, counterregulation, and energy homeostasis. Physiology (Bethesda), 22, 241–251.
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N.E., Schatz, A.R., Gopher, A., Almog, S., Martin, B.R., & Compton, D.R. (1995). Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochemical Pharmacology, 50, 83–90.
Meier, U., & Gressner, A.M. (2004). Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clinical Chemistry, 50, 1511–1525.
Menéndez, C., Baldelli, R., Camiña, J.P., Escudero, B., Peino, R, Diéguez, C., & Casanueva, F.F (2003). TSH stimulates leptin secretion by a direct effect on adipocytes. Journal of Endocrinology, 176, 7–12.
Mondal, M.S., Nakazato, M., Date, Y., Murakami, N., Yanagisawa, M., & Matsukura, S. (1999). Widespread distribution of orexin in rat brain and its regulation upon fasting. Biochemical and Biophysical Research Communications, 256, 495–499.
Mori, H., Hanada, R., Hanada, T., Aki, D., Mashima, R., Nishinakamura, H., Torisu, T., Chien, K.R., Yasukawa, H., & Yoshimura, A. (2004). Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nature Medicine, 10, 739–743.
Morton, G.J., Cummings, D.E., Baskin, D.G., Barsh, G.S., & Schwartz, M.W. (2006). Central nervous system control of food intake and body weight. Nature, 443, 289–295.
Murata, M., Okimura, Y., Iida, K., Matsumoto, M., Sowa, H., Kaji, H., Kojima, M., Kangawa, K., & Chihara, K. (2002). Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. The Journal of Biological Chemistry, 277, 5667–5674.
Murphy, K.G., Dhillo, W.S., & Bloom, S.R. (2006). Gut peptides in the regulation of food intake and energy homeostasis. Endocrine Reviews, 27, 719–727.
Myers, M.G. Jr. (2004). Leptin receptor signaling and the regulation of mammalian physiology. Recent Progress in Hormone Research, 59, 287–304.
Näslund, E., Barkeling, B., King, N., Gutniak, M., Blundell, J.E., Holst, J.J., Rössner S., & Hellström, P.M. (1999). Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. International Journal of Obesity and Related Metabolic Disorders, 23, 304–311.
Niswender, K.D., & Schwartz, M.W. (2003). Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities. Frontiers in Neuroendocrinology, 24, 1–10.
Nonaka, N., Shioda, S., Niehoff, M.L., & Banks, W.A. (2003). Characterization of blood-brain barrier permeability to PYY3-36 in the mouse. Journal of Pharmacology and Experimental Therapeutics, 306, 948–953.
Norman, D., Isidori, A.M., Frajese, V., Caprio, M., Chew, S.L., Grossman, A.B., Clark, A.J., Michael Besser, G., & Fabbri, A. (2003). ACTH and alpha-MSH inhibit leptin expression and secretion in 3T3-L1 adipocytes: model for a central-peripheral melanocortin-leptin pathway. Molecular and Cellular Endocrinology, 200, 99–109.
Obici, S., Feng, Z., Morgan, K., Stein, D., Karkanias, G., & Rossetti L. (2002a). Central administration of oleic acid inhibits glucose production and food intake. Diabetes, 51, 271–275.
Obici, S., Feng, Z., Karkanias, G., Baskin, D.G., & Rossetti, L. (2002b). Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nature Neuroscience, 5, 566–572.
Oh-I, S., Shimizu, H., Satoh, T., Okada, S., Adachi, S., Inoue, K., Eguchi, H., Yamamoto, M., Imaki, T., Hashimoto, K., Tsuchiya, T., Monden, T., Horiguchi, K., Yamada, M., & Mori, M. (2006). Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature, 443, 709–712.
Okamoto, H., Nakae, J., Kitamura, T., Park, B.C., Dragatsis, I., & Accili, D. (2004). Transgenic rescue of insulin receptor-deficient mice. Journal of Clinical Investigation, 114, 214–223.
Orosco, M., Gerozissis, K., Rouch, C., & Nicolaïdis, S. (1995). Feeding-related immunoreactive insulin changes in the PVN-VMH revealed by microdialysis. Brain Research, 671, 149–158.
Pal, R., & Sahu, A. (2003). Leptin signaling in the hypothalamus during chronic central leptin infusion. Endocrinology, 144, 3789–3798.
Pan, W., Hsuchou, H., & Kastin, A.J. (2007). Nesfatin-1 crosses the blood-brain barrier without saturation. Peptides, 28, 2223–2228.
Pelleymounter, M.A., Cullen, M.J., Baker, M.B., Hecht, R., Winters, D., Boone, T., & Collins, F. (1995). Effects of the obese gene product on body weight regulation in ob/ob mice. Science, 269, 540–543.
Perseghin, G., Petersen, K., & Shulman, G.I. (2003). Cellular mechanism of insulin resistance: potential links with inflammation. International Journal of Obesity and Related Metabolic Disorders, 27 (Suppl 3), S6–S11.
Sahu, A. (2004). Minireview: a hypothalamic role in energy balance with special emphasis on leptin. Endocrinology, 145, 2613–2620.
Sarkar, S., Wittmann, G., Fekete, C., & Lechan, R.M. (2004). Central administration of cocaine-and amphetamine-regulated transcript increases phosphorylation of cAMP response element binding protein in corticotrophin-releasing hormone-producing neurons but not in protyrotropin-releasing hormone-producing neurons in the hypothalamic paraventricular nucleus. Brain Research, 999, 181–192.
Scarpace, P.J. & Zhang, Y. (2009). Leptin resistance: a predisposing factor for diet-induced obesity. American Journal of Regulatory and Integrative Comparative Physiology, 296, R493–R500.
Schäffler, A., Schölmerich, J., & Buechler, C. (2006). The role of ‘adipotropins’ and the clinical importance of a potential hypothalamic-pituitary-adipose axis. Nature Clinical Practice Endocrinology & Metabolism, 2, 374–383.
Schwartz, M.W., Woods, S.C., Porte, D. Jr., Seeley, R.J., & Baskin, D.G. (2000). Central nervous system control of food intake. Nature, 404, 661–671.
Shimokawa, T., Kumar, M.V., & Lane, M.D. (2002). Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides. Proceedings of the National Academy of Sciences of the United States of America, 99, 66–71.
Shintani, M., Nishimura, H., Akamizu, T., Yonemitsu, S., Masuzaki, H., Ogawa, Y., Hosoda, K., Inoue, G., Yoshimasa, Y., & Nakao, K. (1999). Thyrotropin decreases leptin production in rat adipocytes. Metabolism, 48, 1570–1574.
Sindelar, D.K., Mystkowski, P., Marsh, D.J., Palmiter, R.D., & Schwartz, M.W. (2002). Attenuation of diabetic hyperphagia in neuropeptide Y-deficient mice. Diabetes, 51, 778–783.
Sone, M., & Osamura, R.Y. (2001). Leptin and the pituitary. Pituitary, 4, 15–23.
Soriano-Guillén, L., Barrios, V., Campos-Barros, A., & Argente, J. (2004). Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation. The Journal of Pediatrics, 144, 36–42.
Sorisky, A., Bell, A., & Gagnon, A. (2000). TSH receptor in adipose cells. Hormone and Metabolic Research, 32, 468–474.
South, T., & Huang, X.F. (2008). Temporal and site-specific brain alterations in CB1 receptor binding in high fat diet-induced obesity in C57BI/6 mice. Journal of Neuroendocrinology, 20, 1288–1294.
Spranger, J., Verma, S., Göhring, I., Bobbert, T., Seifert, J., Sindler, A.L., Pfeiffer, A., Hileman, S.M., Tschöp, M., & Banks, W.A. (2006). Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes, 55, 141–147.
Stengel, A., Goebel, M., Yakubov, I., Wang, L., Witcher, D., Coskun, T., Taché, Y., Sachs, G., & Lambrecht, N.W. (2008). Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology [doi: 10.1210/en.2008-00747].
Swart, I., Jahng, J.W., Overton, J.M., & Houpt, T.A. (2002). Hypothalamic NPY, AGRP, and POMC mRNA responses to leptin and refeeding in mice. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 283, R1020–R1026.
Takenoya, F., Funahashi, H., Matsumoto, H., Ohtaki, T., Katoh, S., Kageyama, H., Suzuki, R., Takeuchi, M., & Shioda, S. (2002). Galanin-like peptide is co-localized with alpha-melanocyte stimulating hormone but not with neuropeptide Y in the rat brain. Neuroscience Letters, 331, 119–122.
Takenoya, F., Aihara, K., Funahashi, H., Matsumoto, H., Ohtaki, T., Tsurugano, S., Yamada, S., Katoh, S., Kageyama, H., Takeuchi, M., & Shioda, S. (2003). Galanin-like peptide is target for regulation by orexin in the rat hypothalamus. Neuroscience Letters, 340, 209–212.
Ter Horst, G.J., de Boer, P., Luiten, P.G., & van Willigen, J.D. (1989). Ascending projections from the solitary tract nucleus to the hypothalamus. A Phaseolus vulgaris lectin tracing study in the rat. Neuroscience, 31, 785–797.
Toshinai, K., Yamaguchi, H., Sun, Y., Smith, R.G., Yamanaka, A., Sakurai, T., Date, Y., Mondal, M.S., Shimbara, T., Kawagoe, T., Murakami, N., Miyazato, M., Kangawa, K., & Nakazato, M. (2006). Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology, 147, 2306–2314.
Tovar, S., Nogueiras, R., Tung, L.Y., Castañeda, T.R., Vázquez, M.J., Morris, A., Williams, L.M., Dickson, S.L., & Diéguez, C. (2005). Central administration of resistin promotes short-term satiety in rats. European Journal of Endocrinology, 153, R1–R5.
Tucci, S.A., Rogers, E.K., Korbonits, M., & Kirkham, T.C. (2004). The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigeneic effects of intrahypothalamic ghrelin. British Journal of Pharmacology, 143, 520–523.
Urban, J.H., Bauer-Dantoin, A.C., & Levine, J.E. (1993). Neuropeptide Y gene expression in the arcuate nucleus: sexual dimorphism and modulation by testosterone. Endocrinology, 132, 139–145.
Vicentic, A., & Jones, D.C. (2007). The CART (cocaine-and amphetamine-regulated transcript) system in appetite and drug addiction. Journal of Pharmacology and Experimental Therapeutics, 320, 499–506.
Viengchareun, S., Bouzinba-Segard, H., Laigneau, J.P., Zennaro, M.C., Kelly, P.A., Bado, A., Bado, A., Lombès, M., & Binart, N. (2004). Prolactin potentiates insulin-stimulated leptin expression and release from differentiated brown adipocytes. Journal of Molecular Endocrinology, 33, 679–691.
Vrang, N., Larsen, P.J., Clausen, J.T., & Kristensen, P. (1999). Neurochemical characterization of the hypothalamic cocaine-amphetamine-regulated transcript neurons. The Journal of Neuroscience, 19, RC5: 1–8.
Wallenius, K., Wallenius, V., Sunter, D., Dickson, S.L., & Jansson, J.O. (2002). Intracerebroventricular interleukin-6 treatment decreases body fat in rats. Biochemical and Biophysical Research Communication, 293, 560–565.
Williams, D.L., Kaplan, J.M., & Grill, H.J. (2000). The role of the dorsal vagal complex and the vagus nerve in feeding effects of melanocortin-3/4 receptor stimulation. Endocrinology, 141, 1332–1337.
Woods, S.C., & D’Alessio, D.A. (2008). Central control of body weight and appetite. The Journal of Clinical Endocrinology and Metabolism, 93, S37–S50.
Wynne, K., & Bloom, S.R. (2006). The role of oxyntomodulin and peptide tyrosine-tyrosine (PYY) in appetite control. Nature Clinical Practice Endocrinology and Metabolism, 2, 612–620.
Wynne, K., Stanley S., McGowan, B., & Bloom, S. (2005a). Appetite control. The Journal of Endocrinology, 184, 291–318.
Wynne, K., Park, A.J., Small, C.J., Patterson, M., Ellis, S.M., Murphy, K.G., Wren, A.M., Frost, G.S., Meeran, K., Ghatei, M.A., & Bloom, S.R. (2005b). Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial. Diabetes, 54, 2390–2395.
Xu, B., Goulding, E.H., Zang, K., Cepoi, D., Cone, R.D., Jones, K.R., Tecott, L.H., & Reichardt, L.F. (2003). Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nature Neuroscience, 6, 736–742.
Xue, B., Kim, Y.B., Lee, A., Toschi, E., Bonner-Weir, S., Kahn, C.R., Neel, B.G., & Kahn, B.B. (2007). Protein-tyrosine phosphatase 1B deficiency reduces insulin resistance and the diabetic phenotype in mice with polygenic insulin resistance. The Journal of Biological Chemistry, 282, 23829–23840.
Yang, X.J., Kow, L.M., Pfaff, D.W., & Mobbs, C.V. (2004). Metabolic pathways that mediate inhibition of hypothalamic neurons by glucose. Diabetes, 53, 67–73.
Zarjevski, N., Cusin, I., Vettor, R., Rohner-Jeanrenaud, F., & Jeanrenaud, B. (1993). Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology, 133, 1753–1758.
Zhang, J.V., Ren, P.G., Avsian-Kretchmer, O., Luo, C.W., Rauch, R., Klein, C., & Hsueh, A.J. (2005). Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin’s effects on food intake. Science, 310, 996–999.
Zhao, A.Z., Shinohara, M.M., Huang, D., Shimizu, M., Eldar-Finkelman, H., Krebs, E.G., Beavo, J.A., & Bornfeldt, K.E. (2000). Leptin induces insulin-like signaling that antagonizes cAMP elevation by glucagon in hepatocytes. The Journal of Biological Chemistry, 275, 11348–11354.
Ziotopoulou, M., Mantzoros, C.S., Hileman, S.M., & Flier, J.S. (2000). Differential expression of hypothalamic neuropeptides in the early phase of diet-induced obesity in mice. American Journal of Physiology, Endocrinology and Metabolism, 279, E838–E845.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Barrios, V., Martos-Moreno, G.Á., Frago, L.M., Chowen, J.A., Argente, J. (2011). Neuroendocrine Regulation. In: Moreno, L., Pigeot, I., Ahrens, W. (eds) Epidemiology of Obesity in Children and Adolescents. Springer Series on Epidemiology and Public Health, vol 2. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6039-9_16
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6039-9_16
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-6038-2
Online ISBN: 978-1-4419-6039-9
eBook Packages: MedicineMedicine (R0)